- Home
- PLYM vs BCAX Comparison
PLYM vs BCAX Comparison
Compare PLYM & BCAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLYM
- BCAX
- Stock Information
- Founded
- PLYM 2011
- BCAX 2018
- Country
- PLYM United States
- BCAX United States
- Employees
- PLYM N/A
- BCAX N/A
- Industry
- PLYM Real Estate Investment Trusts
- BCAX
- Sector
- PLYM Real Estate
- BCAX
- Exchange
- PLYM Nasdaq
- BCAX NYSE
- Market Cap
- PLYM 794.4M
- BCAX 670.9M
- IPO Year
- PLYM 2017
- BCAX 2024
- Fundamental
- Price
- PLYM $15.71
- BCAX $12.97
- Analyst Decision
- PLYM Buy
- BCAX Buy
- Analyst Count
- PLYM 9
- BCAX 7
- Target Price
- PLYM $21.44
- BCAX $29.67
- AVG Volume (30 Days)
- PLYM 377.4K
- BCAX 586.0K
- Earning Date
- PLYM 05-01-2025
- BCAX 05-20-2025
- Dividend Yield
- PLYM 6.13%
- BCAX N/A
- EPS Growth
- PLYM 600.05
- BCAX N/A
- EPS
- PLYM 3.05
- BCAX N/A
- Revenue
- PLYM $180,505,000.00
- BCAX N/A
- Revenue This Year
- PLYM $4.40
- BCAX N/A
- Revenue Next Year
- PLYM $8.36
- BCAX N/A
- P/E Ratio
- PLYM $5.10
- BCAX N/A
- Revenue Growth
- PLYM N/A
- BCAX N/A
- 52 Week Low
- PLYM $12.70
- BCAX $8.91
- 52 Week High
- PLYM $24.71
- BCAX $28.09
- Technical
- Relative Strength Index (RSI)
- PLYM 59.57
- BCAX N/A
- Support Level
- PLYM $15.05
- BCAX N/A
- Resistance Level
- PLYM $15.73
- BCAX N/A
- Average True Range (ATR)
- PLYM 0.40
- BCAX 0.00
- MACD
- PLYM 0.19
- BCAX 0.00
- Stochastic Oscillator
- PLYM 97.24
- BCAX 0.00
About PLYM Plymouth Industrial REIT Inc.
Plymouth Industrial REIT Inc is a full-service, vertically integrated, self-administered, and self-managed Maryland corporation. It is focused on the acquisition, ownership, and management of single and multi-tenant Class B industrial properties, including distribution centers, warehouses, and light industrial properties, located in secondary and primary markets across the United States. The company has one reportable segment, which is Industrial properties. The majority of its property portfolio is spread across Florida, Ohio, Indiana, Tennessee, Illinois and Georgia, among others. It receives income from the rental revenue through its properties.
About BCAX BICARA THERAPEUTICS INC
Bicara Therapeutics Inc is a clinical-stage biopharmaceutical company bringing transformative bifunctional therapies to patients with solid tumors. Its program ficerafusp alfa is a bifunctional antibody that combines two clinically validated targets, an epidermal growth factor receptor, or EGFR, directed monoclonal antibody with a domain that binds to human transforming growth factor beta, or TGF-b.